Proteomic investigation of 5-fluorouracil resistance in a human hepatocellular carcinoma cell line

Journal of Cellular Biochemistry

Volumn 113, Issue 5, 2012, Pages 1671-1680

  Tong, Shi Wen ^a   Yang, Yi Xuan ^a   Hu, Huai Dong ^a   An, Xuan ^a   Ye, Feng ^a   Hu, Peng ^a   Ren, Hong ^a   Li, Sang Lin ^a   Zhang, Da Zhi ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

HEPATOCELLULAR CARCINOMA; iTRAQ; MASS SPECTROMETRY; MULTI DRUG RESISTANCE

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

ADULT; AGED; ANNEXIN A3; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTEOMICS; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; TANDEM MASS SPECTROMETRY;

EID: 84859079794     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24036     Document Type: Article

References (39)

1. Fellenberg J, Kunz P, Sahr H, Depeweg D,. 2010. Overexpression of inosine 5'-monophosphate dehydrogenase type II mediates chemoresistance to human osteosarcoma cells. PloS One 5: e12179.
2. Finlayson AE, Freeman KW,. 2009. A cell motility screen reveals role for MARCKS-related protein in adherens junction formation and tumorigenesis. PloS One 4: e7833.
3. Flick DA, Gifford GE,. 1984. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 68: 167-175. (Pubitemid 14133657)
4. Fu C, Wu C, Liu T, Ago T, Zhai P, Sadoshima J, Li H,. 2009. Elucidation of thioredoxin target protein networks in mouse. Mol Cell Proteomics 8: 1674-1687.
5. Guo T, Gan CS, Zhang H, Zhu Y, Kon OL, Sze SK,. 2008. Hybridization of pulsed-Q dissociation and collision-activated dissociation in linear ion trap mass spectrometer for iTRAQ quantitation. J Proteome Res 7: 4831-4840.
6. Harashima M, Harada K, Ito Y, Hyuga M, Seki T, Ariga T, Yamaguchi T, Niimi S,. 2008. Annexin A3 expression increases in hepatocytes and is regulated by hepatocyte growth factor in rat liver regeneration. J Biochem 143: 537-545. (Pubitemid 351451770)
7. Ho J, Kong JW, Choong LY, Loh MC, Toy W, Chong PK, Wong CH, Wong CY, Shah N, Lim YP,. 2009. Novel breast cancer metastasis-associated proteins. J Proteome Res 8: 583-594.
8. Jin J, Huang M, Wei HL, Liu GT,. 2002. Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel (7402). World J Gastroenterol 8: 1029-1034. (Pubitemid 35446415)
9. Kerbel RS, Kobayashi H, Graham CH,. 1994. Intrinsic or acquired drug resistance and metastasis: Are they linked phenotypes? J Cell Biochem 56: 37-47. (Pubitemid 24288108)
10. Kusuhara H, Suzuki H, Terasaki T, Kakee A, Lemaire M, Sugiyama Y,. 1997. P-Glycoprotein mediates the efflux of quinidine across the blood-brain barrier. J Pharmacol Exp Ther 283: 574-580. (Pubitemid 27514613)
11. Li F, Zhang D, Fujise K,. 2001. Characterization of fortilin, a novel antiapoptotic protein. J Biol Chem 276: 47542-47549.
12. Liao F, Liu M, Lv L, Dong W,. 2010. Hepatoma-derived growth factor promotes the resistance to anti-tumor effects of nordihydroguaiaretic acid in colorectal cancer cells. Eur J Pharmacol 645: 55-62.
13. Liu L, Ning X, Sun L, Zhang H, Shi Y, Guo C, Han S, Liu J, Sun S, Han Z, Wu K, Fan D,. 2008. Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci 99: 121-128. (Pubitemid 350239040)
14. Livak KJ, Schmittgen TD,. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
15. McMillan TJ, Hart IR,. 1987. Can cancer chemotherapy enhance the malignant behaviour of tumours? Cancer Metast Rev 6: 503-519.
16. Morrow CS, Diah S, Smitherman PK, Schneider E, Townsend AJ,. 1998. Multidrug resistance protein and glutathione S-transferase P1-1 act in synergy to confer protection from 4-nitroquinoline 1-oxide toxicity. Carcinogenesis 19: 109-115. (Pubitemid 28376832)
17. Morrow CS, Smitherman PK, Townsend AJ,. 2000. Role of multidrug-resistance protein 2 in glutathione S-transferase P1-1-mediated resistance to 4-nitroquinoline 1-oxide toxicities in HepG2 cells. Mol Carcinog 29: 170-178.
18. Moss SE, Morgan RO,. 2004. The annexins. Genome Biol 5: 219.
19. Nedjadi T, Kitteringham N, Campbell F, Jenkins RE, Park BK, Navarro P, Ashcroft F, Tepikin A, Neoptolemos JP, Costello E,. 2009. S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility. Br J Cancer 101: 1145-1154.
20. Oikawa K, Ohbayashi T, Mimura J, Fujii-Kuriyama Y, Teshima S, Rokutan K, Mukai K, Kuroda M,. 2002. Dioxin stimulates synthesis and secretion of IgE-dependent histamine-releasing factor. Biochem Biophys Res Commun 290: 984-987. (Pubitemid 34687459)
21. Park JE, Lee DH, Lee JA, Park SG, Kim NS, Park BC, Cho S,. 2005. Annexin A3 is a potential angiogenic mediator. Biochem Biophys Res Commun 337: 1283-1287. (Pubitemid 41505261)
22. Parkin DM, Bray F, Ferlay J, Pisani P,. 2001. Estimating the world cancer burden: Globocan 2000. International journal of cancer. J Int Cancer 94: 153-156. (Pubitemid 32911406)
23. Penuelas S, Noe V, Ciudad CJ,. 2005. Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells. FEBS J 272: 696-710. (Pubitemid 40208873)
24. Perez-Tomas R,. 2006. Multidrug resistance: Retrospect and prospects in anti-cancer drug treatment. Curr Med Chem 13: 1859-1876.
25. Plumb JA, Milroy R, Kaye SB,. 1989. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res 49: 4435-4440. (Pubitemid 19208340)
26. Rangiah K, Tippornwong M, Sangar V, Austin D, Tetreault MP, Rustgi AK, Blair IA, Yu KH,. 2009. Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer. J Proteome Res 8: 5153-5164.
27. Schwartz JD, Schwartz M, Mandeli J, Sung M,. 2002. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: Review of the randomised clinical trials. Lancet Oncol 3: 593-603. (Pubitemid 35174678)
28. Sturzenbaum SR, Kille P, Morgan AJ,. 1998. Identification of heavy metal induced changes in the expression patterns of the translationally controlled tumour protein (TCTP) in the earthworm Lumbricus rubellus1. Biochim Biophys Acta 1398: 294-304. (Pubitemid 28338166)
29. Tan YH, Lee KH, Lin T, Sun YC, Hsieh-Li HM, Juan HF, Wang YC,. 2008. Cytotoxicity and proteomics analyses of OSU03013 in lung cancer. Clin Cancer Res 14: 1823-1830. (Pubitemid 351469469)
30. Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK, Kwok TT,. 2008. Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells. Apoptosis 13: 1135-1147.
31. Vercoutter-Edouart AS, Czeszak X, Crepin M, Lemoine J, Boilly B, Le Bourhis X, Peyrat JP, Hondermarck H,. 2001. Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells. Exp Cell Res 262: 59-68. (Pubitemid 32989008)
32. Wang HY, Zhang JY, Cui JT, Tan XH, Li WM, Gu J, Lu YY,. 2010. Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery. Oncol Rep 23: 45-52.
33. Yan XD, Pan LY, Yuan Y, Lang JH, Mao N,. 2007. Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines. J Proteome Res 6: 772-780. (Pubitemid 46340180)
34. Yang YX, Chen ZC, Zhang GY, Yi H, Xiao ZQ,. 2008. A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line. J Cell Biochem 104: 1010-1021. (Pubitemid 351830847)
35. Yang Y, Lim SK, Choong LY, Lee H, Chen Y, Chong PK, Ashktorab H, Wang TT, Salto-Tellez M, Yeoh KG, Lim YP,. 2010. Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins. J Proteome Res 9: 4767-4778.
36. Yarm FR,. 2002. Plk phosphorylation regulates the microtubule-stabilizing protein TCTP. Mol Cell Biol 22: 6209-6221. (Pubitemid 34857840)
37. Zhang F, Zhang L, Zhang B, Wei X, Yang Y, Qi RZ, Ying G, Zhang N, Niu R,. 2009. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells. J Proteome Res 8: 5041-5047.
38. Zimmermann A, Gu JJ, Spychala J, Mitchell BS,. 1996. Inosine monophosphate dehydrogenase expression: Transcriptional regulation of the type I and type II genes. Adv Enzyme Regul 36: 75-84. (Pubitemid 27065705)
39. Zimmermann AG, Gu JJ, Laliberte J, Mitchell BS,. 1998. Inosine-5'-monophosphate dehydrogenase: Regulation of expression and role in cellular proliferation and T lymphocyte activation. Prog Nucleic Acid Res Mol Biol 61: 181-209.